Main Article Content
Background Sepsis may lead to acute kidney injury (AKI)
in patients treated in pediatric intensive care units (PICU).
Currently, serum creatinine is used as a biomarker for the
diagnosis of AKI. However, it is not a sensitive nor specific
test for AKI. The scarcity of biomarkers leads to delays in the
diagnosis and treatment of AKI. Serum cystatin-C (sCys-C)
and urinary neutrophil gelatinase-associated lipocalin (uNGAL)
are potential biomarkers that look promising for early diagnosis
Objective To identify the relation of cystatin-C and NGAL in
children with sepsis.
Methods Serum cystatin-C and uNGAL were measured on
septic patients aged one month to 12 years. The diagnoses
of sepsis were based on the 2002 International Pediatric Sepsis
Concensus. Patients were admitted to the Pediatric Intensive
Department of the Prof. Dr. R. D. Kandou Hospital, Manado
from January to June 2013. The exclusion criteria were
patients with trauma, burns, severe dehydration, malnutrition,
obesity, and history of renal diseases. Data analyses included
descriptions for the characteristic data and Pearson’s coefficient
correlation. A P value of 0.05 was considered to be statistically
significant. Data were analyzed with SPSS software for Windows
Results Thirty-eight patients met the inclusion criteria, of whom
23 were male and 15 were female. Their mean age was 22.6 (SD
32.24) months, with overweight in 2 children, good nutrition in
25 children, and under nutrition in 11 children. An increased
level of sCys-C was found in 22 children and an increased level
of uNGAL was found in 19 children. Serum cystatin-C was
significantly correlated to uNGAL in septic patients (r=0.614;
Conclusion There is a positively correlated relationship between
sCys C and uNGAL in septic children. Increased sCys C is associated with increased uNGAL in septic children.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
2. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA. 1995:273;117-23.
3. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatso H, Morgera S, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005:294;813-8.
4. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001:29;1303-10.
5. Edelstein CL and Schrier RW. Pathophysiology of ischemic acute renal failure. In: Schrier RW, editor. Diseases of the kidney and urinary tract. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1041-69.
6. Cowland JB, Borregaard N. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics. 1997:45;17-23.
7. Cowland JB, Sorensen OE, Sehested M, Borregaard N.Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 but not by TNF-. J Immunol. 2003;171:6630-9. 8. Mishra J, Mori K, Ma Q, Kelly C, Yang J, Mitsnefes M, et al.
8. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol. 2004:15;3073-82.
9. Bagshaw SM, Bellomo R. Cystatin C in acute kidney injury. Curr Opin Crit Care. 2010;16:533-9.
10. Goldstein B, Giroir B, Randolph A, members of International Consensus Conference on Pediatric Sepsis. International pediatrics sepsis concensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6:2-8.
11. Bagshaw S, Bennett M, Haase M, Haase-Fielitz A, Egi M, Morimatsu H, D’amico G, et al. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med. 2010;36:452–61.
12. Wheeler DS, Devarajan P, Ma Q, Harmon K, Monaco M, Cvijanovich N, Wong HR. Serum neutrophil gelatinaseassociated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med. 2008;36:1297–303.
13. Bailey D, Phan V, Litalien C, Ducruet T, Mérouani A, Lacroix J, et al. Risk factors of acute renal failure in critically ill children: a prospective descriptive epidemiological study. Pediatr Crit Care Med. 2007;8:29–35.
14. Seitz S, Rauh M, Gloeckler M, Cesnjevar R, Dittrich S, Koch AM. Cystatin C and neutrophil gelatinase-associated lipocalin: biomarkers for acute kidney injury after congenital heart surgery. Swiss Med Wkly. 2013;143:13744.